Compared to Estimates, Health Catalyst (HCAT) Q3 Earnings: A Look at Key Metrics
For the quarter ended September 2023, Health Catalyst (HCAT) reported revenue of $73.77 million, up 7.9% over the same period last year. EPS came in at $0.03, compared to -$0.13 in the year-ago quarter.
The reported revenue represents a surprise of +1.67% over the Zacks Consensus Estimate of $72.56 million. With the consensus EPS estimate being -$0.03, the EPS surprise was +200.00%.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how Health Catalyst performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
Revenue- Professional services: $27.80 million compared to the $26.69 million average estimate based on seven analysts. The reported number represents a change of +14.1% year over year.
Revenue- Technology: $45.97 million compared to the $45.98 million average estimate based on seven analysts. The reported number represents a change of +4.5% year over year.
Adjusted Gross Profit- Professional Services: $3.21 million compared to the $4.05 million average estimate based on five analysts.
Adjusted Gross Profit- Technology: $31.37 million compared to the $31.42 million average estimate based on five analysts.
View all Key Company Metrics for Health Catalyst here>>>
Shares of Health Catalyst have returned -27% over the past month versus the Zacks S&P 500 composite's -1.1% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Health Catalyst, Inc. (HCAT) : Free Stock Analysis Report
